ReviewInflammopharmacology2026

Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination.

Ghada A Badawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.